Literature DB >> 6985612

Absence of fibronectin and presence of plasminogen activator in both normal and malignant human mammary epithelial cells in culture.

N S Yang, W Kirkland, T Jorgensen, P Furmanski.   

Abstract

Primary monolayer cultures of normal and malignant human mammary epithelial cells were tested for fibronectin by indirect immunofluorescence using antisera specific for fibronectin. This protein was not detectable on either the normal or malignant epithelial cells. Similar results were obtained for normal and malignant mouse mammary epithelial cell cultures. Control normal and transformed fibroblasts exhibited the expected result: the normal cells were positive and the transformed cells were negative. With the use of supernatant fluids from the same cultures or an agar-overlay assay on viable cells, high levels of plasminogen-dependent fibrinolytic activity were detectable in both the normal and malignant mammary cells. Thus, two characteristics that distinguish normal from transformed fibroblasts do not serve as markers of malignancy in mammary epithelial/carcinoma systems.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6985612      PMCID: PMC2110535          DOI: 10.1083/jcb.84.1.120

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  41 in total

1.  Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

Authors:  J Unkeless; K Dano; G M Kellerman; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

2.  A comparison of membrane proteins of normal and transformed cells by lactoperoxidase labeling.

Authors:  N M Hogg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

3.  Fibrinolysis associated with oncogenic transformation. Morphological correlates.

Authors:  L Ossowski; J P Quigley; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

4.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

5.  Normal human mammary cells in culture: evidence for oncornavirus-like particles.

Authors:  P Furmanski; C Longley; D Fouchey; R Rich; M A Rich
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

6.  Immunofluorescent localization of mammary tumor virus antigens in mammary tumor cells in culture.

Authors:  C M McGrath; P B Blair
Journal:  Cancer Res       Date:  1970-07       Impact factor: 12.701

7.  Isolation of a major cell surface glycoprotein from fibroblasts.

Authors:  K M Yamada; J A Weston
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

8.  A permanent heteroploid human cell line with type B glucose-6-phosphate dehydrogenase.

Authors:  W D Peterson; C S Stulberg; W F Simpson
Journal:  Proc Soc Exp Biol Med       Date:  1971-04

9.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

10.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses.

Authors:  L Ossowski; J C Unkeless; A Tobia; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

View more
  11 in total

1.  Tumor promoters induce a specific morphological signature in the nuclear matrix-intermediate filament scaffold of Madin-Darby canine kidney (MDCK) cell colonies.

Authors:  E G Fey; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

2.  Effect of the extracellular matrix on plasminogen activator isozyme activities of human mammary epithelial cells in culture.

Authors:  N S Yang; C Park; C Longley; P Furmanski
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

3.  The early appearance of fibronectin in the course of metastatic tumor growth in lymph nodes.

Authors:  D Lorke; P Möller
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

4.  Laminin and fibronectin in adenoid cystic carcinoma.

Authors:  A J d'Ardenne; P Kirkpatrick; C A Wells; J D Davies
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

5.  In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.

Authors:  D H Cresson; W C Beckman; R R Tidwell; J D Geratz; G P Siegal
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

6.  Isolation and characterization of a serially cultivated, neoplastic, epithelial cell line from the N-nitrosomethylurea induced rat mammary adenocarcinoma.

Authors:  L A Cohen
Journal:  In Vitro       Date:  1982-06

7.  Heterogeneous distribution of actin, myosin, fibronectin and basement membrane antigens in primary and metastatic human breast cancer.

Authors:  P G Natali; P Giacomini; G Bigotti; M R Nicotra; M Bellocci; C De Martino
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  Fibronectin and type III collagen in epithelial neoplasms of gastrointestinal tract and salivary gland.

Authors:  A J D'Ardenne; J Burns; B C Sykes; M K Bennett
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

9.  In vivo demonstration of cytoplasmic fibronectin in human breast carcinomas.

Authors:  L Christensen; M Nielsen; B Hølund; I Clemmensen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Possible functions of mesenchyme cell-derived fibronectin during formation of basal lamina.

Authors:  A G Brownell; C C Bessem; H C Slavkin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.